市場調査レポート
商品コード
1297750

医療向けデジタルツインの世界市場:コンポーネント別 (ソフトウェア、サービス)・用途別 (個別化医療、創薬、医学教育、ワークフロー最適化)・エンドユーザー別 (医療提供者、研究・学術機関、支払者)・地域別の将来予測 (2028年まで)

Digital Twins in Healthcare Market by Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2028

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 208 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
医療向けデジタルツインの世界市場:コンポーネント別 (ソフトウェア、サービス)・用途別 (個別化医療、創薬、医学教育、ワークフロー最適化)・エンドユーザー別 (医療提供者、研究・学術機関、支払者)・地域別の将来予測 (2028年まで)
出版日: 2023年06月06日
発行: MarketsandMarkets
ページ情報: 英文 208 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の医療向けデジタルツインの市場規模は、予測期間中に67.0%のCAGRで成長し、2023年の16億米ドルから、2028年には211億米ドルに達すると予測されています。

様々な医療用アプリケーションをサポートするデジタルツインの技術進歩や、新興市場でのデジタルツイン技術の採用拡大が、予測期間中に市場に有利な機会を提供しています。

"個別化医療分野が、2022年に用途別で大きなシェアを占める"

2022年には、個別化医療セグメントが医療向けデジタルツイン市場でかなりのシェアを占めました。このセグメントの成長は、患者モデリングの改善、リスク要因の最小化、患者転帰の向上などの能力に起因しており、医療業界で非常に著名な活用領域となっています。個別化医療はまた、患者固有の特性に基づいて個々の患者に合わせた治療を提供し、それゆえ治療介入を最適化し、成功する転帰の可能性を高めるという際立った利点を提供します。

"エンドユーザー別では、医療提供者の分野が2022年に大幅なシェアを占める"

2022年には、医療向けデジタルツイン市場で、医療提供者のセグメントが大幅なシェアを占めました。医療提供者セグメントは、ワークフロー管理と手術計画における重要な役割により、医療向けデジタルツイン市場を独占しています。デジタルツインはまた、正確な患者モデリング、パーソナライズされた治療計画、モニタリングなどの様々な付加的な利点を提供し、臨床意思決定と患者転帰の改善につながります。

"アジア太平洋地域が予測期間中に大幅な成長率で成長する"

アジア太平洋市場は、予測期間中に最も高いCAGRで成長すると予測されています。市場の主な促進要因として、最先端技術 (IoT・遠隔医療など) の需要増大や、政府のイニシアティブ、研究・ゲノム目的のデジタルツイン、新興国におけるデジタルツインの認知度向上と採用、医療ツーリズムの増加、医療インフラの改善などが挙げられます。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 市場促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 業界考察

  • 業界動向
  • テクノロジー分析
  • ポーターのファイブフォース分析
  • 規制状況
  • バリューチェーン分析
  • エコシステム/市場マップ
  • 特許分析
  • 隣接市場分析
  • ケーススタディ分析
  • 主要な利害関係者と購入基準
  • 主要な会議とイベント (2023年~2024年)
  • バイヤーに影響を与える動向/混乱

第7章 医療向けデジタルツイン市場:コンポーネント別

  • イントロダクション
  • サービス
  • ソフトウェア

第8章 医療向けデジタルツイン市場:用途別

  • イントロダクション
  • 創薬・開発
  • 個別化医療
  • 手術計画・医学教育
  • 医療機器の設計・試験
  • 医療ワークフロー最適化と資産管理
  • その他の用途

第9章 医療向けデジタルツイン市場:エンドユーザー別

  • イントロダクション
  • 製薬・バイオ医薬品企業
  • 研究・学術機関
  • 医療提供者
  • 医療機器企業
  • その他のエンドユーザー

第10章 医療向けデジタルツイン市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他の欧州
  • アジア太平洋
    • 日本
    • 中国
    • その他のアジア太平洋
  • その他の地域

第11章 競合情勢

  • 概要
  • 市場ランキング分析
  • 上位企業の収益シェア分析
  • 医療向けデジタルツイン市場:研究開発 (R&D) 支出
  • 競合ベンチマーキング
  • 企業評価クアドラント
  • スタートアップ/中小企業向け企業評価マトリクス
  • 競合シナリオ

第12章 企業プロファイル

  • 主要企業
    • MICROSOFT
    • SIEMENS HEALTHINEERS AG
    • KONINKLIJKE PHILIPS N.V.
    • AMAZON (AWS)
    • DASSAULT SYSTEMES
    • GE HEALTHCARE
    • ORACLE
    • IBM
    • PTC
    • SAP
    • ATOS SE
    • NVIDIA CORPORATION
    • ANSYS INC.
    • FASTSTREAM TECHNOLOGIES
    • RESCALE, INC.
  • その他の企業
    • TWIN LTD.
    • VERTO HEALTH
    • QBIO
    • THOUGHTWIRE
    • SIM AND CURE
    • PREDICTIV
    • NUREA
    • UNLEARN.AI
    • VIRTONOMY GMBH
    • PREDISURGE

第13章 付録

目次
Product Code: HIT 8675

The global digital twin healthcare market is projected to reach USD 21.1 billion by 2028 from USD 1.6 billion in 2023, at a high CAGR of 67.0% during the forecast period. The technological advancements in digital twins supporting various healthcare applications and the growing adoption of digital twin technology in emerging markets will provide lucrative opportunities to the market during the forecast period.

"Personalized medicine segment accounted for a substantial share of the digital twins in healthcare market, by Application in 2022."

In 2022, the personalized medicine segment accounted for a substantial share of the digital twins in healthcare market. The growth of this segment is attributed to its ability to improved patient modeling, minimized risk factors, and enhanced patient outcomes, making it a highly prominent application in the healthcare industry. Personalized medicine also offers an undistinguished advantage of tailoring treatments to individual patients based on their unique characteristics and hence optimizing therapeutic interventions, increasing the likelihood of successful outcomes.

"Healthcare Providers segment accounted for a considerable share in the digital twins in healthcare market, by end user in 2022"

In 2022, the healthcare providers segment accounted for a significant share of the digital twins in healthcare market. The healthcare provider segment dominates the digital twin healthcare market due to its vital role in workflow management and surgical planning. Digital twins also offers various additional advantages such as accurate patient modeling, personalized treatment planning, and monitoring, leading to improved clinical decision-making and patient outcomes.

"Asia Pacific to witness the substantial growth rate during the forecast period."

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Factors such as growing demand for advanced technologies such as increased adoption of technologies such as IoT, telemedicine, government initiatives, digital twin for research & genomics purposes, growing awareness and adoption of digital twin in emerging regions, growing medical tourism, and improving healthcare infrastructure.

The break-down of primary participants is as mentioned below:

  • By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
  • By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
  • By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, Rest of the World: 10%

Key Players in the Digital twins in the Healthcare Market

The key players operating in the digital twin in healthcare market include Siemens Healthineers AG (Germany), Dassault Systemes (France), Microsoft (US), Koninklijke Philips N.V. (Netherlands), Faststream Technologies (US), Twin LTD (US), IBM (US), NVIDIA Corporation (US), GE Healthcare (US), NUREA (France), ANSYS, Inc. (US), Rescale, Inc. (US), Predictiv (US), Verto Health (Canada), PrediSurge (France), Qbio (US), Virtonomy GmbH (Germany), Unlearn AI (US), Atos SE (France), ThoughtWire (Canada), Amazon Web Services, Inc.(US), Oracle(US), PTC (US), SAP (Germany), Sim and Cure (France).

Research Coverage:

The report analyzes the Digital Twins in Healthcare Market and aims to estimate the market size and future growth potential of various market segments, based on components, application, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of key drivers (increasing Investments in digital twins in developed as well as emerging technology adoption, rising demand for personalized medicine, increasing funding and investments in digital twin startups), restraints (accuracy and privacy issues with digital twin systems and high implementation costs), opportunities (growing importance of digital twin Iin emerging market, increasing focus on cutting edge real-time data analytics), and challenges (lack of technical expertise & data management issues) influencing the growth of the digital twin market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the digital twins in healthcare market.
  • Market Development: Comprehensive information on the lucrative emerging markets, component, application, end-user, and region.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the digital twins in healthcare market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the digital twins in healthcare market like Siemens Healthineers AG (Germany), Dassault Systemes (France), Microsoft (US), Koninklijke Philips N.V. (Netherlands), Faststream Technologies (US), IBM (US), NVIDIA Corporation (US), GE Healthcare (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • TABLE 1 INCLUSIONS & EXCLUSIONS
  • 1.3 STUDY SCOPE
    • FIGURE 1 DIGITAL TWINS IN HEALTHCARE MARKET SEGMENTATION
    • 1.3.1 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY
    • TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • 1.5 STAKEHOLDERS
  • 1.6 LIMITATIONS
  • 1.7 IMPACT OF RECESSION

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primaries
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
      • 2.1.2.3 Insights from primary experts
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 BOTTOM-UP APPROACH
    • FIGURE 6 TOP-DOWN APPROACH
    • FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF DIGITAL TWINS IN HEALTHCARE INDUSTRY
    • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3 MARKET BREAKDOWN DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 3 RISK ASSESSMENT: DIGITAL TWINS IN HEALTHCARE MARKET
  • 2.8 IMPACT OF RECESSION ON DIGITAL TWINS IN HEALTHCARE MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 10 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF DIGITAL TWINS IN HEALTHCARE MARKET

4 PREMIUM INSIGHTS

  • 4.1 DIGITAL TWINS IN HEALTHCARE MARKET OVERVIEW
    • FIGURE 14 INCREASING USE OF DIGITAL TWINS AND GROWING IMPORTANCE OF PATIENT-CENTRIC CARE IN HEALTHCARE TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT AND COUNTRY
    • FIGURE 15 SOFTWARE SEGMENT TO COMMAND LARGEST SHARE OF ASIA PACIFIC MARKET IN 2023
  • 4.3 GEOGRAPHIC SNAPSHOT OF DIGITAL TWINS IN HEALTHCARE MARKET
    • FIGURE 16 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • 4.4 REGIONAL MIX: DIGITAL TWINS IN HEALTHCARE MARKET
    • FIGURE 17 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.5 DIGITAL TWINS IN HEALTHCARE MARKET: DEVELOPED VS. DEVELOPING ECONOMIES
    • FIGURE 18 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 DIGITAL TWINS IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 4 MARKET DYNAMICS: DIGITAL TWINS IN HEALTHCARE MARKET
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Increasing investments by public and private entities
      • 5.2.1.2 Growing applications of digital twins
      • 5.2.1.3 Technological advancements
      • 5.2.1.4 Growing funding and investments in digital twin start-ups
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Managing data quality, privacy issues, and high implementation costs
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing focus on cutting-edge real-time data analytics
      • 5.2.3.2 Growing importance of digital twins in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of skilled professionals
      • 5.2.4.2 Integration with existing systems and outdated digital infrastructure

6 INDUSTRY INSIGHTS

  • 6.1 INDUSTRY TRENDS
    • 6.1.1 TRANSFORMATION IN CLINICAL TRIALS
    • 6.1.2 REVOLUTIONIZING MEDICAL TRAINING AND DIAGNOSTICS
    • 6.1.3 IMPROVING OPERATIONAL EFFICIENCY IN HOSPITALS
  • 6.2 TECHNOLOGY ANALYSIS
    • 6.2.1 TECHNOLOGY STACK
    • FIGURE 20 DIGITAL TWIN TECHNOLOGIES
      • 6.2.1.1 5G networks
      • 6.2.1.2 Internet of Things
      • 6.2.1.3 Cloud and edge computing
      • 6.2.1.4 Blockchain
      • 6.2.1.5 Augmented reality, virtual reality, and mixed reality
      • 6.2.1.6 Artificial intelligence and machine learning
  • 6.3 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 21 DIGITAL TWINS IN HEALTHCARE MARKET: PORTER'S FIVE FORCES ANALYSIS
    • TABLE 5 DIGITAL TWINS IN HEALTHCARE MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 6.3.1 INTENSITY OF COMPETITIVE RIVALRY
    • 6.3.2 BARGAINING POWER OF SUPPLIERS
    • 6.3.3 BARGAINING POWER OF BUYERS
    • 6.3.4 THREAT OF NEW ENTRANTS
    • 6.3.5 THREAT OF SUBSTITUTES
  • 6.4 REGULATORY LANDSCAPE
    • 6.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 DIGITAL TWINS IN HEALTHCARE MARKET: REGULATORY STANDARDS
  • 6.5 VALUE CHAIN ANALYSIS
    • FIGURE 22 VALUE CHAIN ANALYSIS (2022)
    • 6.5.1 PLANNING & REVISING FUNDS
    • 6.5.2 RESEARCH & DEVELOPMENT
    • 6.5.3 SOFTWARE DESIGN, FRAMEWORK, AND DEVELOPMENT
    • 6.5.4 PRODUCT/SOLUTION PROVIDERS
    • 6.5.5 END USERS AND AFTER-SALES SERVICE PROVIDERS
  • 6.6 ECOSYSTEM/MARKET MAP
    • FIGURE 23 DIGITAL TWINS IN HEALTHCARE MARKET: ECOSYSTEM
  • 6.7 PATENT ANALYSIS
    • FIGURE 24 NUMBER OF PATENTS PUBLISHED, JANUARY 2013 TO MARCH 2023
    • FIGURE 25 TOP PATENT OWNERS IN DIGITAL TWINS IN HEALTHCARE MARKET
    • TABLE 11 KEY PATENTS IN DIGITAL TWINS IN HEALTHCARE MARKET
  • 6.8 ADJACENT MARKET ANALYSIS
    • FIGURE 26 METAVERSE IN HEALTHCARE MARKET: MARKET OVERVIEW
  • 6.9 CASE STUDY ANALYSIS
  • 6.10 KEY STAKEHOLDERS & BUYING CRITERIA
    • 6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
    • TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
    • 6.10.2 BUYING CRITERIA
    • FIGURE 28 KEY BUYING CRITERIA FOR DIGITAL TWIN COMPONENTS
    • TABLE 13 KEY BUYING CRITERIA FOR DIGITAL TWIN COMPONENTS
  • 6.11 KEY CONFERENCES & EVENTS, 2023-2024
    • TABLE 14 DIGITAL TWINS IN HEALTHCARE MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 6.12 TRENDS/DISRUPTIONS IMPACTING BUYERS
    • FIGURE 29 DIGITAL TWINS IN HEALTHCARE MARKET: TRENDS/DISRUPTIONS IMPACTING BUYERS

7 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT

  • 7.1 INTRODUCTION
    • TABLE 15 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • 7.2 SERVICES
    • 7.2.1 INTRODUCTION OF COMPLEX SOFTWARE TO DRIVE DEMAND FOR SERVICES
    • TABLE 16 DIGITAL TWINS IN HEALTHCARE SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 SOFTWARE
    • 7.3.1 SHIFT TO WEB/CLOUD-BASED MODELS TO SUPPORT GROWTH
    • TABLE 17 KEY SOFTWARE SOLUTIONS OFFERED BY MARKET PLAYERS
    • TABLE 18 DIGITAL TWINS IN HEALTHCARE SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 19 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 DRUG DISCOVERY & DEVELOPMENT
    • 8.2.1 ABILITY OF DIGITAL TWINS TO ENHANCE DRUG DISCOVERY & DEVELOPMENT TO BOOST MARKET
    • TABLE 20 DIGITAL TWINS IN HEALTHCARE MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 PERSONALIZED MEDICINE
    • 8.3.1 QUICK AND COST-EFFECTIVE DEVELOPMENT AND TESTING OF PERSONALIZED DIAGNOSTICS TO SUPPORT MARKET
    • TABLE 21 DIGITAL TWINS IN HEALTHCARE MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 SURGICAL PLANNING & MEDICAL EDUCATION
    • 8.4.1 ABILITY OF DIGITAL TWINS TO ENHANCE SURGICAL TRAINING AND SIMULATE SURGICAL PROCEDURES TO BOOST ADOPTION
    • TABLE 22 DIGITAL TWINS IN HEALTHCARE MARKET FOR SURGICAL PLANNING & MEDICAL EDUCATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 MEDICAL DEVICE DESIGN & TESTING
    • 8.5.1 POTENTIAL OF DIGITAL TWINS TO STREAMLINE OPERATIONS, MINIMIZE RISK, AND REDUCE DOWNTIME TO PROMOTE USE
    • TABLE 23 DIGITAL TWINS IN HEALTHCARE MARKET FOR MEDICAL DEVICE DESIGN & TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.6 HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT
    • 8.6.1 ADVANTAGES SUCH AS IMPROVED EFFICIENCY AND VALUABLE INSIGHTS TO SUPPORT DEMAND
    • TABLE 24 DIGITAL TWINS IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.7 OTHER APPLICATIONS
    • TABLE 25 DIGITAL TWINS IN HEALTHCARE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

9 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 26 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 PHARMA & BIOPHARMA COMPANIES
    • 9.2.1 RISING DEMAND FOR SOLUTIONS TO REDUCE TIME AND COST OF DRUG DEVELOPMENT TO BOOST ADOPTION
    • TABLE 27 DIGITAL TWINS IN HEALTHCARE MARKET FOR PHARMA & BIOPHARMA COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 RESEARCH & ACADEMIA
    • 9.3.1 INTERACTIVE AND IMMERSIVE LEARNING EXPERIENCES OFFERED BY DIGITAL TWINS TO BOOST ADOPTION
    • TABLE 28 DIGITAL TWINS IN HEALTHCARE MARKET FOR RESEARCH & ACADEMIA, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 HEALTHCARE PROVIDERS
    • 9.4.1 LOWER COSTS AND BETTER PATIENT TREATMENT TO FAVOR MARKET GROWTH
    • TABLE 29 DIGITAL TWINS IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.5 MEDICAL DEVICE COMPANIES
    • 9.5.1 GROWING USE OF DIGITAL TWINS FOR SOFTWARE OPTIMIZATION OF MEDICAL DEVICES TO FUEL GROWTH
    • TABLE 30 DIGITAL TWINS IN HEALTHCARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.6 OTHER END USERS
    • TABLE 31 DIGITAL TWINS IN HEALTHCARE MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 32 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 30 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET SNAPSHOT
    • TABLE 33 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 35 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 36 NORTH AMERICA: DIGITAL TWINS IN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Expanding applications of digital twins in healthcare to bolster market growth
    • TABLE 37 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 38 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 39 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Growing investments in digital twin development to drive market
    • TABLE 40 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 41 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 42 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 43 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 45 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 46 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Collaborations & partnerships to drive adoption of digital twins
    • TABLE 47 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 48 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 49 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Growing applications of digital twins to support growth
    • TABLE 50 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 51 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 52 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Growing government funding for digital twin development to bolster growth
    • TABLE 53 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 54 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 55 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 REST OF EUROPE
    • TABLE 56 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 57 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 58 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 31 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET SNAPSHOT
    • TABLE 59 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 61 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 62 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Growing penetration of digital twin technologies to support market growth
    • TABLE 63 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 64 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 65 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 China to register highest CAGR during forecast period
    • TABLE 66 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 67 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 68 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 REST OF ASIA PACIFIC
    • TABLE 69 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 70 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 71 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • TABLE 72 REST OF THE WORLD: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 73 REST OF THE WORLD: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 74 REST OF THE WORLD: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
    • FIGURE 32 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2020 AND MAY 2023
  • 11.2 MARKET RANKING ANALYSIS
    • FIGURE 33 DIGITAL TWINS IN HEALTHCARE MARKET RANKING ANALYSIS, BY PLAYER, 2022
  • 11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 34 DIGITAL TWINS IN HEALTHCARE MARKET: REVENUE ANALYSIS OF KEY PLAYERS
  • 11.4 DIGITAL TWINS IN HEALTHCARE MARKET: R&D EXPENDITURE
    • FIGURE 35 R&D EXPENDITURE OF KEY PLAYERS (2021 VS. 2022)
  • 11.5 COMPETITIVE BENCHMARKING
    • TABLE 75 FOOTPRINT OF COMPANIES IN DIGITAL TWINS IN HEALTHCARE MARKET
    • TABLE 76 COMPANY COMPONENT FOOTPRINT (20 COMPANIES)
    • TABLE 77 COMPANY APPLICATION FOOTPRINT (20 COMPANIES)
    • TABLE 78 COMPANY REGIONAL FOOTPRINT (20 COMPANIES)
  • 11.6 COMPANY EVALUATION QUADRANT
    • 11.6.1 STARS
    • 11.6.2 EMERGING LEADERS
    • 11.6.3 PERVASIVE PLAYERS
    • 11.6.4 PARTICIPANTS
    • FIGURE 36 DIGITAL TWINS IN HEALTHCARE MARKET: COMPANY EVALUATION QUADRANT (2022)
  • 11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 DYNAMIC COMPANIES
    • 11.7.3 RESPONSIVE COMPANIES
    • 11.7.4 STARTING BLOCKS
    • FIGURE 37 DIGITAL TWINS IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
  • 11.8 COMPETITIVE SCENARIO
    • 11.8.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
    • TABLE 79 PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020- MAY 2023
    • 11.8.2 DEALS
    • TABLE 80 DEALS, JANUARY 2020- MAY 2023

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 MICROSOFT
    • TABLE 81 MICROSOFT: BUSINESS OVERVIEW
    • FIGURE 38 MICROSOFT: COMPANY SNAPSHOT (2022)
    • 12.1.2 SIEMENS HEALTHINEERS AG
    • TABLE 82 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
    • FIGURE 39 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2022)
    • 12.1.3 KONINKLIJKE PHILIPS N.V.
    • TABLE 83 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
    • FIGURE 40 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
    • 12.1.4 AMAZON (AWS)
    • TABLE 84 AMAZON: BUSINESS OVERVIEW
    • FIGURE 41 AMAZON: COMPANY SNAPSHOT (2022)
    • 12.1.5 DASSAULT SYSTEMES
    • TABLE 85 DASSAULT SYSTEMES: BUSINESS OVERVIEW
    • FIGURE 42 DASSAULT SYSTEMES: COMPANY SNAPSHOT (2022)
    • 12.1.6 GE HEALTHCARE
    • TABLE 86 GE HEALTHCARE: BUSINESS OVERVIEW
    • FIGURE 43 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
    • 12.1.7 ORACLE
    • TABLE 87 ORACLE: BUSINESS OVERVIEW
    • FIGURE 44 ORACLE: COMPANY SNAPSHOT (2022)
    • 12.1.8 IBM
    • TABLE 88 IBM: BUSINESS OVERVIEW
    • FIGURE 45 IBM: COMPANY SNAPSHOT (2022)
    • 12.1.9 PTC
    • TABLE 89 PTC: BUSINESS OVERVIEW
    • FIGURE 46 PTC: COMPANY SNAPSHOT (2022)
    • 12.1.10 SAP
    • TABLE 90 SAP: BUSINESS OVERVIEW
    • FIGURE 47 SAP: COMPANY SNAPSHOT (2022)
    • 12.1.11 ATOS SE
    • TABLE 91 ATOS SE: BUSINESS OVERVIEW
    • FIGURE 48 ATOS SE: COMPANY SNAPSHOT (2022)
    • 12.1.12 NVIDIA CORPORATION
    • TABLE 92 NVIDIA CORPORATION: BUSINESS OVERVIEW
    • FIGURE 49 NVIDIA CORPORATION: COMPANY SNAPSHOT (2022)
    • 12.1.13 ANSYS INC.
    • TABLE 93 ANSYS INC.: BUSINESS OVERVIEW
    • FIGURE 50 ANSYS INC.: COMPANY SNAPSHOT (2022)
    • 12.1.14 FASTSTREAM TECHNOLOGIES
    • TABLE 94 FASTSTREAM TECHNOLOGIES: BUSINESS OVERVIEW
    • 12.1.15 RESCALE, INC.
    • TABLE 95 RESCALE, INC.: BUSINESS OVERVIEW
  • 12.2 OTHER PLAYERS
    • 12.2.1 TWIN LTD.
    • TABLE 96 TWIN LTD.: BUSINESS OVERVIEW
    • 12.2.2 VERTO HEALTH
    • TABLE 97 VERTO HEALTH: BUSINESS OVERVIEW
    • 12.2.3 QBIO
    • TABLE 98 QBIO: BUSINESS OVERVIEW
    • 12.2.4 THOUGHTWIRE
    • TABLE 99 THOUGHTWIRE: BUSINESS OVERVIEW
    • 12.2.5 SIM AND CURE
    • TABLE 100 SIM AND CURE: BUSINESS OVERVIEW
    • 12.2.6 PREDICTIV
    • TABLE 101 PREDICTIV: BUSINESS OVERVIEW
    • 12.2.7 NUREA
    • TABLE 102 NUREA: BUSINESS OVERVIEW
    • 12.2.8 UNLEARN.AI
    • TABLE 103 UNLEARN.AI: BUSINESS OVERVIEW
    • 12.2.9 VIRTONOMY GMBH
    • TABLE 104 VIRTONOMY GMBH: BUSINESS OVERVIEW
    • 12.2.10 PREDISURGE
    • TABLE 105 PREDISURGE: BUSINESS OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS